| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Vigabatrin | FAERS: 13 | US FAERS | |
| 2 | Fingolimod Hydrochloride | FAERS: 4 | US FAERS | |
| 3 | Pregabalin | FAERS: 2 | US FAERS | |
| 4 | Capecitabine | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 6 | Droxidopa | FAERS: 1 | US FAERS | |
| 7 | Gatifloxacin | FAERS: 1 | US FAERS | |
| 8 | Hydroxychloroquine | FAERS: 1 | US FAERS | |
| 9 | Hydroxychloroquine | FAERS: 1 | US FAERS | |
| 10 | Loratadine and pseudoephedrine sulfate | FAERS: 1 | US FAERS | |
| 11 | Methimazole | FAERS: 1 | US FAERS | |
| 12 | Milnacipran | FAERS: 1 | US FAERS | |
| 13 | Risedronic Acid | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 15 | Tadalafil | FAERS: 1 | US FAERS | |
| 16 | chloroquine diphosphate | FAERS: 1 | US FAERS | |
| 17 | telithromycin | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.